Related Experiment Video
Updated: Jan 7, 2026

08:31
Acellular and Cellular Lung Model to Study Tumor Metastasis
Published on: August 19, 2018
7.9K
Habitat Model Based on Lung CT for Predicting Brain Metastasis in Patients with Non-Small Cell Lung Cancer
Feiyu Xing1,2, Yan Lei1,2, Qin Zhong2
1School of Medicine, Jianghan University, Wuhan 430056, China.
Diagnostics (Basel, Switzerland)
|December 11, 2025
Summary
A new radiomics model analyzing lung tumor subregions accurately predicts brain metastasis risk in non-small cell lung cancer (NSCLC) patients. This habitat-based approach, using CT scans, shows superior performance over whole-tumor analysis for early detection.
Area of Science:
- Radiomics and Medical Imaging
- Oncology
- Computational Pathology
Background:
- Brain metastasis (BM) in lung cancer is linked to primary tumor heterogeneity.
- Predicting BM risk is crucial for non-small cell lung cancer (NSCLC) patient management.
- Enhanced CT imaging offers potential for non-invasive tumor characterization.
Purpose of the Study:
- To develop and validate a habitat-based radiomics model for predicting BM risk in NSCLC.
- To assess the model's performance against a whole-tumor radiomics approach.
- To investigate the role of subregional tumor heterogeneity in BM development.
Main Methods:
- Retrospective analysis of 195 NSCLC patients with enhanced CT lung imaging.
- Segmentation of tumors into subregions using k-means clustering (intensity, entropy).
- Radiomics feature extraction and selection; logistic regression models (whole-tumor vs. habitat-based).
Main Results:
- The habitat-based radiomics model achieved an AUC of 0.819, outperforming the whole-tumor model (AUC 0.728).
- The habitat-based model showed significantly superior predictive performance (p=0.022).
- Subregional heterogeneity analysis was key to the improved prediction accuracy.
Conclusions:
- Habitat-based radiomics models effectively predict BM risk in NSCLC.
- Analyzing subregional tumor heterogeneity is vital for improving predictive accuracy.
- This approach enhances risk stratification for NSCLC patients.

